Jenny Sundqvist
Chief Executive Officer chez INDEX PHARMACEUTICALS HOLDING AB
Profil
Jenny Sundqvist is currently the Chief Executive Officer at InDex Pharmaceuticals Holding AB.
Previously, she worked as the Chief Commercial Officer at Isofol Medical AB.
From 2017 to 2021, she held the position of Head-Oncology Portfolio at AstraZeneca PLC.
Ms. Sundqvist completed her undergraduate degree at Louisiana State University and obtained an MBA from McCombs School of Business.
Postes actifs de Jenny Sundqvist
| Sociétés | Poste | Début |
|---|---|---|
| INDEX PHARMACEUTICALS HOLDING AB | Chief Executive Officer | 01/01/2023 |
Anciens postes connus de Jenny Sundqvist
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/04/2021 |
| ISOFOL MEDICAL AB | Corporate Officer/Principal | - |
Formation de Jenny Sundqvist
| Louisiana State University | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| INDEX PHARMACEUTICALS HOLDING AB | Health Technology |
| ISOFOL MEDICAL AB | Health Technology |
